These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 21642990)

  • 41. Reprogramming of miRNA networks in cancer and leukemia.
    Volinia S; Galasso M; Costinean S; Tagliavini L; Gamberoni G; Drusco A; Marchesini J; Mascellani N; Sana ME; Abu Jarour R; Desponts C; Teitell M; Baffa R; Aqeilan R; Iorio MV; Taccioli C; Garzon R; Di Leva G; Fabbri M; Catozzi M; Previati M; Ambs S; Palumbo T; Garofalo M; Veronese A; Bottoni A; Gasparini P; Harris CC; Visone R; Pekarsky Y; de la Chapelle A; Bloomston M; Dillhoff M; Rassenti LZ; Kipps TJ; Huebner K; Pichiorri F; Lenze D; Cairo S; Buendia MA; Pineau P; Dejean A; Zanesi N; Rossi S; Calin GA; Liu CG; Palatini J; Negrini M; Vecchione A; Rosenberg A; Croce CM
    Genome Res; 2010 May; 20(5):589-99. PubMed ID: 20439436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
    He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Divergent influence of microRNA-21 deletion on murine colitis phenotypes.
    Wu F; Dong F; Arendovich N; Zhang J; Huang Y; Kwon JH
    Inflamm Bowel Dis; 2014 Nov; 20(11):1972-85. PubMed ID: 25222661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
    Mavrakis KJ; Wolfe AL; Oricchio E; Palomero T; de Keersmaecker K; McJunkin K; Zuber J; James T; Khan AA; Leslie CS; Parker JS; Paddison PJ; Tam W; Ferrando A; Wendel HG
    Nat Cell Biol; 2010 Apr; 12(4):372-9. PubMed ID: 20190740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
    Ballabio E; Mitchell T; van Kester MS; Taylor S; Dunlop HM; Chi J; Tosi I; Vermeer MH; Tramonti D; Saunders NJ; Boultwood J; Wainscoat JS; Pezzella F; Whittaker SJ; Tensen CP; Hatton CS; Lawrie CH
    Blood; 2010 Aug; 116(7):1105-13. PubMed ID: 20448109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia.
    Chen X; Guo Z; Fan S; Sun L; Li H; Zhou J; Li Y
    Pathol Res Pract; 2019 Aug; 215(8):152494. PubMed ID: 31229277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
    Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
    Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of the circulating and the tissue microRNAs after surgery, chemotherapy, and radiotherapy in mice mammary tumor.
    Farsinejad S; Rahaie M; Alizadeh AM; Mir-Derikvand M; Gheisary Z; Nosrati H; Khalighfard S
    Tumour Biol; 2016 Oct; 37(10):14225-14234. PubMed ID: 27565813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
    Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
    Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.
    Shu Y; Wang Y; Lv WQ; Peng DY; Li J; Zhang H; Jiang GJ; Yang BJ; Liu S; Zhang J; Chen YH; Tang S; Wan KX; Yuan JT; Guo W; Fu G; Qi XK; Liu ZD; Liu HY; Yang C; Zhang LH; Liu FJ; Yu J; Zhang PH; Qu B; Zhao H; He TC; Zou L
    Cancer Res; 2020 Mar; 80(5):988-998. PubMed ID: 31822496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
    Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
    J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.